U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
172861172861A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral DensityCompletedHas ResultsPostmenopausal OsteoporosisDrug: Alendronate|Drug: Denosumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00293813
172862172862A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNo Results AvailableOpen-Angle Glaucoma|Ocular HypertensionDrug: Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution|Drug: Latanoprost 0.005% Ophthalmic Solution (XALATAN)|Drug: Timolol 0.5% Ophthalmic Solution|Other: Timolol Vehiclehttps://ClinicalTrials.gov/show/NCT00293800
172863172863A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNo Results AvailableOpen-angle Glaucoma|Ocular HypertensionDrug: Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution|Other: Timolol Vehicle|Drug: Latanoprost 0.005% Ophthalmic Solution (XALATAN)|Drug: Timolol Maleate Ophthalmic Solution 0.5%https://ClinicalTrials.gov/show/NCT00293787
172864172864Alberta Hip Improvement ProjectActive, not recruitingNo Results AvailableArthroplasty, Replacement, Hiphttps://ClinicalTrials.gov/show/NCT00293774
172865172865A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNo Results AvailableOpen-angle Glaucoma|Ocular HypertensionDrug: Travoprost, Investigational|Drug: Travoprost (TRAVATAN)https://ClinicalTrials.gov/show/NCT00293761
172866172866Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular DiseaseCompletedNo Results AvailableVascular Disease|Vascular Disease Riskhttps://ClinicalTrials.gov/show/NCT00293748
172867172867Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia TrialSuspendedNo Results AvailablePreeclampsia|Pregnancy Induced Hypertension|Gestational Hypertension|Chronic Hypertension|Superimposed PreeclampsiaDrug: labetalol (seizure prevention)|Drug: MgSO4 (seizure prevention)https://ClinicalTrials.gov/show/NCT00293735
172868172868Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by RheumatologistsCompletedHas ResultsArthritis, Psoriatic|Psoriasis|Skin Diseases, PapulosquamousDrug: Etanercepthttps://ClinicalTrials.gov/show/NCT00293722
172869172869Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by DermatologistsCompletedHas ResultsArthritis, Psoriatic|Psoriasis|Skin Diseases, PapulosquamousDrug: etanercepthttps://ClinicalTrials.gov/show/NCT00293709
172870172870Casodex/Zoladex Biomarkers in Localised Prostate CancerCompletedNo Results AvailableProstate CancerDrug: bicalutamide (Casodex), goserelin (Zoladex)https://ClinicalTrials.gov/show/NCT00293696
172871172871A Study Comparing Two Different Techniques for Closing the Skin After a Cesarean DeliveryActive, not recruitingNo Results AvailableCesarean SectionDevice: Insorb absorbable skin staplehttps://ClinicalTrials.gov/show/NCT00293683
172872172872FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate CancerActive, not recruitingNo Results AvailablePatients With T1-4 Advanced Prostate CancerDrug: Goserelin (Zoladex)https://ClinicalTrials.gov/show/NCT00293670
172873172873Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.CompletedNo Results AvailableHeadache (Migraine)Drug: Lornoxicam 8 mg|Drug: Lornoxicam 16 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00293657
172874172874Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy.Active, not recruitingNo Results AvailableHyperemesis Gravidarum|PregnancyDrug: Diclectin®https://ClinicalTrials.gov/show/NCT00293644
172875172875Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After BunionectomyCompletedNo Results AvailableBunionectomy|Orthopedic SurgeryDrug: Lornoxicam 8 mg|Drug: Lornoxicam 16 mg|Drug: Ketorolac 30 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00293631
172876172876Implementation Study of the PostOperative Nausea and Vomiting Prediction RuleCompletedNo Results AvailablePostoperative Nausea and VomitingDevice: Automatic Risk Presentation in the operating room|Other: Education|Other: Feedbackhttps://ClinicalTrials.gov/show/NCT00293618
172877172877Effect of Cemented Stem Design on Periprosthetic Bone Mass Following Primary Total Hip ArthroplastyCompletedNo Results AvailableOsteoarthritisProcedure: Total Hip Replacementhttps://ClinicalTrials.gov/show/NCT00293605
172878172878Dexamethasone for Cardiac Surgery TrialCompletedNo Results AvailableSystemic Inflammatory Response Syndrome|Cardiac Diseases|Postoperative ComplicationsDrug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00293592
172879172879Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck CancerCompletedNo Results AvailableHead and Neck CancerDrug: Pemetrexedhttps://ClinicalTrials.gov/show/NCT00293579
172880172880Clinical Approaches to Ileal Pouch DysfunctionCompletedNo Results AvailablePouchitisProcedure: Electronic Barostathttps://ClinicalTrials.gov/show/NCT00293553
172881172881Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast CancerCompletedNo Results AvailableBreast CancerProcedure: oophorectomy|Drug: Tamoxifenhttps://ClinicalTrials.gov/show/NCT00293540
172882172882Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal CarcinomaWithdrawnNo Results AvailableRenal CancerDrug: Interferon Alpha-2bhttps://ClinicalTrials.gov/show/NCT00293527
172883172883TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)CompletedNo Results AvailablePulmonary Diseases|Intraoperative ComplicationsDrug: Fibrinogen (human) + thrombin (human) (TachoSil)https://ClinicalTrials.gov/show/NCT00293514
172884172884Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By SurgeryActive, not recruitingNo Results AvailableKidney CancerDrug: tinzaparin sodiumhttps://ClinicalTrials.gov/show/NCT00293501
172885172885SL-11047 in Treating Patients With Relapsed or Refractory LymphomaCompletedNo Results AvailableLymphomaDrug: polyamine analogue PG11047https://ClinicalTrials.gov/show/NCT00293488
172886172886Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaRecruitingNo Results AvailableCentral Nervous System LymphomaDrug: Carboplatin|Drug: Mannitol|Drug: Methotrexate|Other: Quality-of-Life Assessment|Biological: Rituximab|Drug: Sodium Thiosulfatehttps://ClinicalTrials.gov/show/NCT00293475
172887172887GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck CancerCompletedHas ResultsHead and Neck Cancer|Mucositis|Radiation ToxicityBiological: sargramostim|Other: oral salt and soda mouthwashhttps://ClinicalTrials.gov/show/NCT00293462
172888172888Celecoxib and Erlotinib in Treating Patients With Liver CancerWithdrawnNo Results AvailableLiver CancerDrug: celecoxib|Drug: erlotinib hydrochloride|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00293436
172889172889GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsBiological: HSPPC-96|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00293423
172890172890Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative DisordersCompletedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Myelodysplastic/Myeloproliferative DiseasesDrug: clofarabine|Drug: cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00293410

* Görseller ve İçerik tekif hakkına sahip olabilir